Blincyto: payments to doctors
Payments that named Blincyto as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.7M
- Providers
- 4,879
- Transactions
- 11,562
- Average per transaction
- $321
The per-transaction average — $321 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,879 providers the average total is $760, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Amgen | $3,710,023 | 100.0% |